Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
Teradyne heads into its October 28 earnings print with options traders at their most defensive in a year, even as the stock has added 20% in a month.
The clearest tension this week is in the options market. The put/call ratio reached 1.47, its highest reading of the past 52 weeks, and is running almost 1.5 standard deviations above its 20-day average of 1.28. That is not a modest skew. It reflects a material step-up in demand for downside protection over the past two to three weeks, a period when the ratio climbed steadily from around 1.12 in early September. Tuesday's session added another data point: the stock fell 3.2% on the day to $430.32, even as the week's net gain still stands at nearly 7%.
Short interest has been building quietly but is not at alarm levels. At 5.4% of free float, it is up more than 26% over the past month in share terms, a meaningful accumulation that has lifted it to the higher end of recent ranges. The one-week change is flat, so the pace of new shorting has paused for now. Borrow conditions give no additional friction: the cost to borrow is a negligible 0.33%, and availability is extremely loose, over 2,700% of short interest, meaning the lending market is nowhere near stressed. Bears can put on positions cheaply and easily, but most have not done so in size.
The Street is broadly constructive, though the consensus has developed some cracks ahead of the print. Most recent analyst activity, concentrated around the July quarter results, involved meaningful target increases. Goldman Sachs moved to $465 from $350 in early July, UBS lifted to $500, and Cantor Fitzgerald and Susquehanna each raised to $550. But Baird's downgrade to Neutral in August, maintaining a $420 target against a stock now trading above that level, is a reminder that not everyone is comfortable with the valuation here. The mean target of around $446 sits just 3.7% above the current price, which implies the Street's bullish moves have largely been absorbed into the share price already. The PE multiple at 38.9x and price-to-book at 13.7x have both risen sharply over the past month, the PE up roughly 6 points in 30 days, consistent with a stock that has re-rated faster than estimates have moved.
The bull case rests on AI-driven semiconductor test demand. Bulls point to AI applications accounting for more than half of semiconductor test revenue, improving HDD test orders, and a path to $5 billion in revenue by 2027. Bears flag smartphone and datacenter demand weakness, potential market share erosion at key customers, and execution risk in the industrial robotics segment. The factor picture supports caution on the value side: the EV/EBITDA multiple at 30.5x, the forward earnings growth score ranked in just the 18th percentile, and the 90-day EPS momentum rank at 77 suggest estimates have been improving recently but the valuation is pricing in a lot.
Recent earnings history adds another layer of interest. The last print, in late July, produced a 14% one-day gain and a 21% five-day gain. That kind of event volatility is exactly what the elevated put/call ratio may be hedging: not a view that the quarter will be bad, but an acknowledgment that the stock moves hard in both directions around results. Peers have broadly tracked higher this week, with COHU up nearly 11% and ACLS up almost 10%, so Teradyne's 7% week is roughly in line with sector momentum rather than a standalone story.
With 21 days to the October 28 print, the question sharpening for investors is whether the AI test revenue mix and HDD recovery are tracking ahead of the elevated bar the market has set, or whether the one-month re-rating has run ahead of what the numbers can support.
See the live data behind this article on ORTEX.
Open TER on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
